RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 103 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296,879 | +41.2% | 12,950 | +1.6% | 0.00% | +50.0% |
| Q2 2023 | $210,264 | -9.8% | 12,751 | -2.4% | 0.00% | 0.0% |
| Q1 2023 | $233,008 | -30.1% | 13,061 | +14.1% | 0.00% | -33.3% |
| Q4 2022 | $333,395 | +32.3% | 11,449 | +11.5% | 0.00% | 0.0% |
| Q3 2022 | $252,000 | +500.0% | 10,271 | +0.4% | 0.00% | – |
| Q2 2022 | $42,000 | -80.3% | 10,230 | +2.0% | 0.00% | -100.0% |
| Q1 2021 | $213,000 | +1.9% | 10,027 | +42.4% | 0.00% | 0.0% |
| Q4 2020 | $209,000 | – | 7,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $9,074,000 | 1.96% |
| NEA Management Company, LLC | 4,912,306 | $49,025,000 | 0.99% |
| RA Capital Management | 4,871,067 | $48,613,000 | 0.86% |
| Samsara BioCapital, LLC | 345,293 | $3,446,000 | 0.67% |
| Endurant Capital Management LP | 197,462 | $1,971,000 | 0.48% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,867,467 | $18,637,000 | 0.39% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $274,000 | 0.20% |
| Baker Brothers Advisors | 3,863,239 | $38,555,000 | 0.19% |
| Rock Springs Capital Management LP | 627,180 | $6,259,000 | 0.14% |
| Aquatic Capital Management LLC | 4,000 | $40,000 | 0.08% |